Archive for February 2019

We’re excited to announce the commencement of our second level 1 clinical study for Revita! This level 1 randomized controlled trial will assess the safety and efficacy of Revita as a wound covering for diabetic foot ulcers (DFUs). Diabetes impacts 30 million people across the United States, and as many as 25% of diabetic patients…